Health Care • Medical Electronics
$76.42 ▲ +0.60
(+0.79%)
MKT CAP: $34.55B • VOL: 4.65M
52W L $59 52W H $90
GEHC // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $20.63B | $19.67B | $19.55B |
| YoY Revenue Growth % | +4.8% | +0.6% | — |
| Gross Profit | $8.25B | $8.21B | $8.60B |
| Gross Margin % | 40.0% | 41.7% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $2.76B | $2.63B | $2.44B |
| Operating Margin % | 13.4% | 13.3% | 12.5% |
| Net Income (GAAP) | $2.08B | $1.99B | $1.57B |
| EBITDA (Normalized) | $3.51B | $3.33B | $3.14B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $2.33B | $2.23B | $1.76B |
| Capital Expenditures (CapEx) | $928.1M | $885.2M | $879.8M |
| Free Cash Flow (FCF) | $1.41B | $1.35B | $876.3M |
| FCF Margin % | 6.8% | 6.8% | 4.5% |
| Return on Invested Capital (ROIC %) | 14.2% | 15.9% | 13.6% |
| Cash & Short-Term Equivalents | $4.49B | $2.87B | $2.58B |
| Total Debt (Short + Long Term) | $9.49B | $7.45B | $5.49B |
| Total Stockholders' Equity | $10.38B | $8.45B | $11.26B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR GEHC.